Presenter

Michael Neal received his Ph.D. in pharmaceutical sciences from the University of Mississippi in 2024. Currently, he investigates the safety and efficacy relationships of natural products through computational techniques, including molecular docking, molecular dynamics, and QSAR. He also computationally probes the pharmacology of GPCRs (such as cannabinoid receptor 1 and mu opioid receptor) as they relate to modulation by Cannabis constituents.